Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Clinical trial NCT00920088 · COMPLETED

Trial details

NCT number: NCT00920088
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Infection, Human Immunodeficiency Virus

Start date: 2009-06-01
Primary completion: 2009-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.